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A CASE – CONTROL STUDY ON CLINICAL SPECTRUM 
AND RISK FACTORS FOR MYOCARDIAL INFARCTION IN 
THE YOUNG ( 40 YRS)  
INTRODUCTION : 
Occlusive arterial disease resulting from atherosclerosis is a leading 
cause of death and disability throughout the world.1-2  
 The global burden of cardiovascular disease carries with it a heavy 
financial burden3 
 Atherosclerosis represents a chronic inflammatory response to vascular 
injury caused by a variety of agents that activate or injure endothelium and 
promote lipoprotein infiltration, retention and modification, combined with 
inflammatory cell entry.4-6 
 Myocardial Infarction generally occurs with the abrupt decrease in 
coronary blood flow that follows a thrombotic occlusion of a coronary artery 
previously narrowed by atherosclerosis.  The injury is produced by or 
facilitated by factors such as cigarette smoking, hypertension, lipid 
accumulation, Diabetes and a number of other factors.  
 A quote from Berkeley heart lab – “Just being an Indian descent puts 
you at a high risk of coronary artery disease”.  The pattern of coronary artery 
disease is indeed changing in India.  It has been reported to be as follows.  
a) Coronary artery disease appears a decade earlier in India than other 
countries.  
b) Males are affected more than females 
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c) Hypertension and Diabetes account for about 40 percent of all cases.  
d) Heavy smoking is an important contributing factor.  
The above findings were based on a clinical study done in Chandigarh in 
persons of age greater than 307 
 The risk of coronary artery disease in Indians is 3-4 times higher than 
white Americans, 6 times higher than Chinese and 20 times higher than 
Japanese.8  
 Indians are prone as a community to coronary artery disease at a much 
younger age.  The disease pattern is severe and diffuse.  Premature coronary 
artery disease is defined as coronary artery disease occurring before the age of 
40 years.  Coronary artery disease is affecting Indians 5-10 years earlier than 
other communities.  Indians also show higher incidence of hospitalization, 
morbidity, and mortality than other ethnic groups.9 
 In some studies from India, the percentage of patients below the age of 
45 years suffering from AMI is reported as high as 25-40%.10 
 Young patients from other communities do not show extensive disease, 
whereas in young Indians there is often triple vessel disease with poor 
prognosis.  The post infarction course in also worse in Indians as compared to 
whites.  This is reflected by three time higher rate of reinfarction and two times 
higher rate of mortaliy.11 
 The prevalence of coronary artery disease according to works done by 
Destefano F, Merrit RK, Anda RF and Bhatia ML12 shows that it is two times 
higher (10%) in urban than in rural India. South Indians have higher prevalence 
7% in rural and 14% in urban areas. The vulnerability of urban Indians to 
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coronary artery disease is possibly related to different nutritional, 
environmental and life style factors.  The BMI in urban Indians as compared to 
rural Indians is 24 VS 20 in males and 25 VS 20 in females.  
 Therefore there has to be a high index of suspicion for coronary artery 
disease in Indians above the age of thirty.  The risk factor evaluation must start 
earlier.  Investigations like tread mill, stress echo, stress thallium and coronary 
angiography should be more liberally recommended.  
 The study conducted as a Case-Control retrospective study, aims at 
evaluating the risk factors involved in development of myocardial infarction 
and the clinical spectrum in the younger (< 40 yrs) age group.  
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REVIEW OF LITERATURE 
 The defining characteristic of the coronary circulation is the direct 
relationship existing between coronary blood flow and myocardial Oxygen 
consumption. The main parameters dictating cardiac Oxygen consumption are 
heart rate (chronotopry) contractility (Inotropy), and LV wall stress.  Whereas 
coronary perfusion at rest in human represents about 200ml/min. it can increase 
up to 1000ml/min on maximal exercise.  This difference represents the 
coronary flow reserve.  The mechanism by which the coronary bed adopts 
blood flow is the cardiac work load represents one component of coronary 
autoregulation, that is the recruitment of the coronary flow reserve to match 
coronary flow to energy needs.  This is accomplished via 1) Endothelial factors 
(Nitric Oxide) 2) Metabolic by products (adenosine) and 3) Neural control 
(both cholinergic and alpha and Beta adrenergic receptors)13 
ANATOMY OF CORONARY CIRCULATION 
 
 The two coronary arteries that supply the myocardium arise from the 
sinuses behind two of the cusps of the aortic value at the root of the aorta.  The 
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right coronary artery dominance in 70% of individuals and the left has 
dominance  in 10% and shared in 20%14 
The left anterior descending  - Anterior wall of left ventricle, anterior 
Coronary Artery   2/3 of interventricular septum. 
Left circumflex coronary Artery - Lateral wall of left ventricle 
Right Coronary Artery - Inferoposterior wall of left ventricle, 
 Post 1/3 of Interventricular septum 
Right atrium & right ventricle.  
 
PRESSURE GRADIENT AND FLOW IN CORONARY VESSELS 
 The heart is a muscle that, like skeletal muscle compresses its blood 
vessels when it contracts.  The pressure inside the ventricle is slightly higher 
than in the aorta in systole, hence flow occurs in the arteries supplying the 
subendocardial portion of the left ventricle only during diastole.  Because there 
is no blood supply during systole in the subendocardial portion of the left 
ventricle, this region is prone to ischemic damage and is the most common site 
of Myocardial Infarction.  On the other hand as the right ventricle pressure 
difference with aorta is greater, the flow in right coronary artery is not reduced 
in systole.13 
CORONARY ANASTOMOSIS?  
 Anastomosis between branches of coronary arteries, subepicardial or 
myocardial and between arteries and extra cardiac vessels are of prime 
importance.  Clinical experience suggests that anastomosis cannot rapidly 
provide collateral routes sufficient to circumvent sudden coronary obstruction.  
It is hence traditional to regard coronary arteries as end arterial.  
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MIOCARDIAL INFARCTION DUE TO CORONARY 
ATHEROSCLEROSIS 
 Myocardial infarction generally occurs with the abrupt decrease in 
Coronary blood flow that follows a thrombotic occlusion of a coronary artery 
previously narrowed by atherosclerosis.  
CORONARY ATHEROSCLEROSIS 
The earliest lesions of atherosclerosis can be found in young children 
and infants in the form of fatty streak whereas the advanced lesion, the fibrous 
plaques, generally appears during early adulthood and progress with age.  
The abdominal aorta is involved earliest.  The aorta is usually most 
heavily involved at or near the orifice of its branches (particularly at the level 
of coronary arteries)  
In coronary arteries, raised lesions are most prominent in the main 
stems, the highest incidence being a short distance beyond the ostia.  
Atherosclerosis is usually always found in the epicardial (extramural) portions 
of the vessels, while the intramural coronary arteries are spared coronary 
atherosclerosis is often diffuse.  The degree to which the lumen is narrowed 
varies, but once the process has commenced, all the intima of the extramural 
portions of the vessels is usually involved.  Typical atheromatous fibrous 
plaques also develop in saphenous vein, which is used for aortocoronary by 
pass graft.  
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HYPOTHESES OF ATHEROSCLEROSIS 
 The response to Injury Hypothesis  
The endothelial lining cells are exposed to repeated or continous insults.  
Dysfunctional endothelial cells at the susceptible sites in the arterial tree would 
lead to exposure of the subendothelial tissue to increased concentrations of 
plasma constituents.  This triggers a sequence of events including monocytes 
and platelet adherence, migration, platelet aggregation and formation of 
microthrombi and release of secretory products.  This causes proliferation of 
smooth muscle cells at these sites of injury.  Monocytes become transformed to 
foam cells.  Thus a well developed plaque is formed.  
 Monoclonal hypothesis  
This states that the intimal proliferative lesion results from the 
multiplication of single, individual smooth muscle cells, as do benign tumors.  
According to this hypothesis, the intimal smooth muscle cell that proliferate to 
form an atheroma are normally under feedback control by mitosis inhibitors 
formed by the smooth muscle cells in the contiguous media, and this feedback 
control system tends to fail with age as these controlling cells die and are not 
adequately replaced.  
RISK FACTORS  
 A number of conditions and habits are present more frequently in 
individuals who develop atherosclerosis than in general population ; these 
factors have been termed risk factors.  
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 The risk factor concept implies that a person with at least one risk factor 
is more likely to develop a clinical atherosclerotic event and is likely to do so 
earlier than a person with no risk factors.  The presence of multiple risk factors 
further accelerates atherosclerosis.  
 Hypercholesterolemia, hypertension and cigarette smoking may be the 
most potent factors for atherosclerosis. Risk factors also vary in terms of their 
potential reversibility with current techniques of preventive management.  
 The American College of Cardiology’s Bethesda Conferences placed 
risk factors into four categories according to the likelihood that modification of 
the factor will result in lower risk.  
 These categories adopted from the 27th Bethesda Conference are as 
follows:  
CATEGORY I 
 Basic research and human observational study indicate a clear causal 
relationship. 
 Intervention data demonstrates the magnitude of the benefit and risk.  
 Interventions are cost-effective and have been proved to lower coronary 
artery disease risk.  
1. Cigarette smoking  
2. LDL Cholesterol 
3. High fat/high cholesterol diet 
4. Hypertension 
5. Left Ventricular Hypertrophy  
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CATEGORY II 
 Studies indicate a casual relationship. 
 Intervention data for large scale trials are limited. 
 Cost effectiveness not ascertained but likely to lower coronary artery 
disease.  
1. Diabetes Mellitus 
2. Physical inactivity 
3. HDL Cholesterol 
4. Triglycerides, ; small, dense LDL 
5. Obesity 
6. Post menopausal status of women  
CATEGORY III 
 Studies indicate association. 
 Interventions have not been tested adequately. 
 Might lower risk. 
1. Psychosocial factors 
2. Lipoprotein (a) 
3. Homocysteine 
4. Oxidative stress 
5. No alcohol consumption. 
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CATEGORY IV 
 Factors associated with coronary artery disease Risk, but cannot be 
modified 
1. Age 
2. Male gender 
3. Low socio economic status 
4. Family history of early onset of coronary artery disease.  
SMOKING  
 A strong dose response relationship between cigarette smoking and 
Coronary Heart Disease has been observed in the young, in the elderly and in 
all recial groups.15 
 Cigarette smoking increases risk 2 to 3 fold and interacts other risk 
factors to multiply risk.  Fitters and modification won’t reduce risk.  Pipe 
smoking and cigar smoking increase the risk of Coronary Heart Disease  
 More than 1 in every 10 Cardiovascular death in the world in the year 
2000 were attributable to smoking.16 
 Exposure to tobacco smoke by non smokers was consistently associated 
with a 20 to 30% increase in risk.17 
 Oxidative stress plays a central role in smoking mediated dysfunction of 
nitric oxide biosynthesis in endothelial cells.  Smoking also lower HDL – C.  
These effects along with direct effects of Carbonmonoxide, nicotine, produce 
endothelial damage.  Smokers have increased vascular reactivity, reduced 
Oxygen Carrying capacity,   lower threshold for myocardial infarction and 
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increased risk of coronary spasm.  Also associated with increased levels of 
fibrinogen and increased platelet aggregability. 
In a previous smoker  the relative risk decline nearly to that of 
nonsmoker in a year or less.18 
Cessation of smoking was found to reduce Coronary Heart Disease 
mortality by 36%.  This reduction does not change with age, gender, country.19 
HYPERTENSION 
 Both systolic and diastolic Hypertension have strong, positive, 
continuous, and graded relationship to Coronary Heart Disease with out 
evidence of threshold risk level of Blood Pressure.20 
A widened pulse pressure an indicator of arterial stiffness is another 
Blood Pressure parameter that predicts Coronary Heart Disease.21 
 Mechanism by which Hypertension may cause coronary events include 
impaired endothelial function, increased endothelial permeability to 
lipoproteins,  increased adherence of leukocytes, increased oxidative stress, 
Hemodynamic stress triggering acute plaque rupture, and increased myocardial 
wall stress and oxygen demand.22 
 In an analysis of 354 randomized trials regimens of multiple drugs given 
at lower dose were estimated capable of reducing systolic BP by 20mm Hg and 
Diastolic BP by 11 mm Hg effects that could result in stroke reduction of 63% 
and Coronary Heart Disease of 46%.23 
 In 2000 the estimated number of adults with Hypertension was 972 
million, 333 million from developed countries, 639 million from developing 
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countries by 2025 the total number of adults with Hypertension is anticipated to 
exceed 1.5 billion.24 
HYPERLIPIDIMIA  
 Both hypercholesterolemia and hypertriglyceridemia are important 
factors for coronary artery disease.  A 10 percent increases in serum cholesterol 
is associated with a 20 to 30 percent increase in risk of coronary artery disease 
and elevations earlier in life may be associated with higher increases in risk.  
 The increases in cholesterol are associated mainly with a raise in LDL 
concentrations; the increases in triglycerides are associated with a raise in 
VLDL and remnants of their catabolism (mainly IDL). Metabolic mechanisms 
have been postulated whereby abdominal obesity, which is associated with 
insulin resistance of peripheral tissues and compensatory hyperinsulinemia, 
promotes enhanced production of triglyceride and cholesterol rich lipoproteins 
by the liver and consequent hyperlipidemia, hypertension and hyperglycemia 
(the insulin resistance syndrome)  
 This is associated unequivocally with increased incidence of premature 
ischemic heart disease.  In Framingham study cholesterol levels in men below 
age 40 were closely related to the future development of ischemic heart 
disease.  This relation was less pronounced in older age group.  In multiple 
Risk Factor Intervention Trial men with cholesterol above 240 mg/dl had more 
than a threefold increase in risk of ischemic heart disease death compared with 
men with cholesterol below 200 mg/dl.  
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 This may be associated with premature atherosclerosis in some specific 
disorders; this association increases the risk of diabetics, hypertensive and 
smokers.  
 According to studies by Moorjani S et al, in Indian patients with 
coronary artery disease high triglyceride levels are found more often than high 
cholesterol levels.  Triglycerides bring change in LDL particle size, density, 
distribution and composition producing smaller, denser, and more atherogenic 
particles.  
 Studies by Jeppesen J, Hein H, suadiciani P, state that an increase of 
triglycerides by 90mg/dl has the same effect on coronary atherosclerosis, as 
increase in age by 10 years.  
 Earlier there has been an under emphasis on the significance of 
triglycerides as risk factor for coronary artery disease.  Indians worldwide have 
demonstrated a traid of high triglycerides with high LDL-C levels and low 
HDL levels. 
 Studies by Kishore S et al25 state that higher level of apolipoprotein B is 
reported in 1/3 of Indian males.  This factor in combination with low levels of 
HDL and Hypertriglyceridaemia result in formation of small dense LDL.  This 
increases the risk of coronary artery disease more than three times.  
 The LDL – cholesterol types are described as phenotypes A, B or C, 
which are genetically determined.  Patients with LDL – phenotype B have 
predominantly small and dense LDL particle which constitute an important risk 
factor for coronary artery disease.  A 75% prevalence of phenotype B is seen in 
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Asian Indians in contrast to 25% in white population26 (Enas EA, Salim 
Yusuf).  
 Clear benefits have been demonstrated for dietary and pharmacological 
treatments that lower serum cholesterol. Treatment aimed at lowering serum 
cholesterol by 10 percent reduces the risk of coronary artery disease by 15 
percent.  
DIABETES AND INSULIN RESISTANCE  
 Insulin resistance and Diabetes mellitus reach among the major 
Cardiovascular risk factors.  
 Patient with Diabetes have 2 – 8 fold of high risk of developing 
Coronary Heart Disease as compared with Age and ethinically matched non 
Diabetic individuals and 75% of all death in Diabetic patients is associated with 
Coronary Heart Disease. 
 Insulin resistance alone confers an elevated risk of Congestive Heart 
Failure and probably explain the association of Obesity it is common vascular 
event.27 
 Diabetes abolish the usual protection from Coronary Heart Disease 
afforded a premenopausal women. Diabetic women have twice the risk of 
recurrent myocardial infarction compared with Diabetic men.28 
 Mechanism by which Diabetic cause atherosclerosis included low HDL-
C, high Triglycerides,  increased lipoprotein remnants, increased small density 
LDL – C, elevated lipoprotein A, increased platelet aggregability, impaired 
endothelial function.  
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 As recently demonstrated in the DM control and complication trial, 
intensive treatment of Diabetes over 6 year period reduced the risk of CHD by 
42%.29 
OBESITY 
 Obesity is defined by the AHA as a major risk factor for Coronary Heart 
Disease.  Obesity is associated with insulin resistance, hyperinsulinemia, Type 
2 DM, Hypertension, Low HDL – C, small dense LDL, inflammation and 
elevated CRP, LVH.30 In women, obesity contributes independently from 
physical activity to the development of Coronary Heart Disease.31 
 Obesity accelerates the progression of coronary atherosclerosis in 
adolescent and young adult men.32 
 Body mass index (BMI) has been adopted widely as a measure of 
adiposity.  BMI is calculated as weight (kg) / Height (m2) 
 Normal Weight   - BMI of 18.5 to 24.9 
 Over Weight   - BMI of 25 to 29.9 
 Obesity   - BMI > 30  
 BMI correlates with total body fat content. In multivariate analysis – 
obesity is not usually found to be an independent risk factor.  Nevertheless 
some large prospective observational studies indicate that obesity is an 
independent risk factor in men and women.33 
 Weight loss improves insulin sensitivity and glucose disposal, reduces 
HBA1C in patients with Type 2 DM, reduces BP and Triglycerides, produces a 
modest reduction in LDL-C, and increases HDL-C. 
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 PHYSICAL INACTIVITY  
 Physical inactivity is an independent risk factor for Coronary Heart 
Disease and roughly doubles the risk.  Physical inactivity slows the progression 
of angiographycally defined coronary atheroscleorsis in human.34 
 Morris and colleagues first reported in the mid-1950 that coronary artery 
disease rates were lower in people who were involved in various physical 
activities than those with sedentary life style.  
 Moderate intensity physical activity reduce the coronary heart disease 
risk by decreasing myocardial oxygen demand, increased myocardial efficiency 
and electrical stability, increased HDL – C, decreasing BP, reducing Obesity,  
improving insulin secretion.  
 The risk of coronary artery disease in sedentary individuals was almost 
twice that of active individuals after controlling for other coronary risk factors.  
Long-term prospective studies of men and women consistently demonstrate 
that regular physical activity protects against death from coronary artery 
disease.  These benefits apply to activities as simple as brisk walking which has 
been shown to reduce the risk of coronary artery disease in women and men as 
well as the risk of type II diabetes.35 
WAIST – HIP RATIO 
 Waist circumference is the minimum circumference measured between 
costal margin and iliac crest and hip circumference is measured over the 
buttocks waist hip circumference ratio more than 0.83 in females and 0.93 in 
males were taken as abnormal. 
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 WHO has adopted BMI  >  25 as over weight.  Studies by Diwivedi 
shows that 80.35% males and 91.66% females were centrally obese, 27.5% 
females who had BMI less than 25 manifested upper segment obesity.  Thus 
waist hip ratio is of great significance. 
PSYCHO SOCIAL FACTORS 
 Psychosocial factors such as depression, absence of social support and 
anger appear to contribute to an elevated risk of coronary artery disease 
although further data are needed to confirm these relationships and establish 
the efficacy of interventional strategies.  
 When the personality characteristics of coronary artery disease patients 
are examined, it is found that there is preponderance of certain type of 
personality traits, known collectively as coronary prone type A behaviour 
(Friedman & Roseman). 
The type A behaviour is characterized by 
1. Time Urgency. 
2. Excessive Competitiveness and hostility 
Overall, there is a chronic struggle to achieve or complete a large 
number of tasks, working against the limits of time available.  
In contrast type B personality is just the opposite, characterized by a 
relaxed unhurried attitude and less vigorous attempts to achieve a goal. 
 Studies of therapeutic interventions suggest a role for improving 
psychosocial factors as part of preventive programs, particularly in secondary 
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prevention.  The strongest evidence comes from post myocardial infarction 
patients.  
 A recent Meta analysis of 37 small studies of health education and stress 
management programs for coronary artery disease patients suggested that such 
efforts might reduce cardiac mortality by 35% and recurrent myocardial 
infarction by 29%.  This is due to favourable effects on blood pressure, 
cholesterol, body weight, smoking behaviour, physical activity and dietary 
habits.  
LIPOPROTEIN A 
The normal function of Lp(a) (Lipoprotein a) is unknown, However Lp 
(a) may inhibit endogenous fibrinolysis by competing with plasminogen for 
binding on endothelial surface and increase the release of PAI. 
 Lipoprotein-a is now recognized as an independent risk factor for 
coronary artery disease.  It is a genetic risk factor.  It is not affected by life 
style modifications like changes in diet and exercise.  Lp-a is ten times more 
atherogenic than LDL-C.  
 Lp-a values are more or les constant in a single individual since birth 
and hence estimation of Lp(a) once in a life time irrespective of age is enough 
for cardio vascular risk assessment.  
 According to studies by Dilip Kr. Mukherjee et al Lp(a) values were 
higher amongst both Indian boys and girls and more so amongst girls compared 
to boys.  
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 Lipoprotein – Level in Boys  19.38 + 5.08 mg % 
       Girls 27.26 + 4.02 mg % 
 Lp(a) promotes early atherosclerosis and thrombosis.  Lp(a) is a stronger 
risk factor than DM for coronary artery disease in younger women.  In Indians, 
both in India and abroad, the levels of Lp(a) are higher as compared to the 
whites, suggesting a genetic propensity (Dwington PN et al). 
 Lp-a levels according to Sahan et al of cord blood are higher among 
Indian newborns than Chinese newborns and this difference is also associated 
with a fourfold higher coronary artery disease – related mortality in Indians 
than Chinese in Singapore.  
 Hunt S et al in his studies state that Lp-a levels over 40 mg/dl increases 
the risk associated with cigarette smoking by 19 times, with DM by 3.4 times, 
with high total cholesterol by 4.2 times, with hypertension by 4.6 times, with 
high TC/HDL ratio by 6.9 times and with high homocysteinemia by 9.3 times.  
 Young individuals who have suffered infarction yet who appear to lack 
any traditional risk factors are more suitable for assessment of Lipoprotein a as 
this would be the contributing factor.  
HOMOCYSTEINE 
 Homocysteine is a highly reactive sulfur containing amino acid that is an 
intermediate product of methionine metabolism Patients with rare inherited 
defects of methionine metabolism can develop severe hyperhomocystinemia 
(Plasma levels > 100 micromol/lt) and can have premature atherothrombosis.36 
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 The mechanisms that account for these effects remain uncertain but may 
include endothelial toxicity accelerated oxidation of LDL-C, impairment of 
Endothelial derived relaxing factor and reduced flow mediated arterial 
vasodilatation.    
 Mild to moderate levels of homocysteine (Plasma level>15 micromol/l) 
are common in general populations, primarily due to insufficient dietary intake 
of folic acid, vitamin B12 other patient groups that tend to have elevated 
homocysteine levels include smoking, alcohol, those with increased Age, male 
sex, menopause common polymorphisms in the methyltetra hydrofolate 
reductase gene, those receiving folate antagonists such as methotextrate, and 
carbamazepine and those with impaired homocysteine metabolism due to 
hypothyroidism or to renal insufficiency.  
 A large series of cross sectional and retrospective studies and a meta 
analysis of 27 observational studies indicate a positive relationship between 
mild to moderate hyperhomocysteinemia and atherosclerosis.37 
 A large cohart study from Norway reported a relative risk of CHD of 1.4 
for every 4 micromole / L. increase in plasma homocysteine.38 
 However because homocysteine levels increase after myocardial 
infarction and stroke such data cannot be used to establish a cause and effect 
relationship.  
 Two large clinical randomized placebo controlled Trials in high risk 
subject found no reduction Cardiovascular events from supplementation with 
folate and Vit B6, B12 , but they shown reduction in Homocysteine level. 
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OXIDATIVE STRESS :  
 Oxidative modification of LDL – has been hypothesized to play a major 
role in the initiation of progression of Atherosclerosis. Naturally occurring anti 
oxidents are Vit E, C & betacarotene.  
 Basic research suggests that Vit E may delay or prevent various steps in 
atherosclerosis.  However randomized trial data are not yet sufficient to fully 
assess the role of vitamin E and Vitamin C or other antioxidants in the primary 
or secondary prevention of atherosclerotic disease.  
 The evidence available does not establish that vitamin E and reduces the 
risk of coronary artery disease.39 Longer follow up of the completed trials, as 
well as ongoing trials, will provide valuable information upon which rational 
clinical decision for individuals and policy for health of the general public can 
be reliably based.  Although it remains unclear whether antioxidant 
supplementation will reduce the risk of chronic disease, consumption of fruits 
and vegetables high in these micronutrients is an important part of healthy diet.  
ALCOHOL INTAKE : 
 Heavy Alcohol intake is associated with increased the risk of death from 
several cause and is a major public health concern.  However cross sectional 
case control and cohart studies indicate that mild to moderate alcohol intake is 
associated with reduced rates of CHD compared with no alcohol intake. These 
studies suggest a “J” shaped relationship between the level of alcohol intake 
and total mortality.40 
 High alcohol intake is associated with an increased risk of high blood 
pressure.  It appears that alcohol consumption raises systolic pressure more 
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than diastolic.  But the finding that blood pressure returns to normal with 
abstinence suggests that alcohol induced elevations may not be fixed, and do 
not necessarily lead to sustained blood pressure elevation.  
 A large Danish population based cohart, women who drug atleast once a 
week had lower risk of CHD than women who drawn less frequently although 
more frequent alcohol consumption did not result in additional risk reduction.41 
 Alcohol intake increase total HDL level as well as HDL2, HDL3 B also 
has potential beneficial effects on fibrinolytic  function, platelet aggregation, 
inflammation, endothelial function.  
AGE 
 Myocardial Infarction risk increases with age.  In the age group less than 
40 years highest incidence is in the age of 35 – 40 years.  Ischemic heart 
disease is the major cause of death in males > 35 and all patients > 45.  
 This can be attributed to the fact that as age increases in both sexes and 
the blood pressure also increases this may also be due to accumulation of 
environmental toxins.  
SEX 
 Atherosclerotic involvement of the coronary arteries is well established 
in man by young adulthood.42 
 Females are generally more protected from myocardial infarction than 
men.  Women seen with a first myocardial infarction tend to be older than men 
with first myocardial infarction.  The gap narrows substantially after 
menopause.  
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 In most studies of young myocardial infarction < 40 years 90% of the 
cases were male.  In females coronary artery disease started 10 years later than 
men and the incidence raised more towards the menopausal age group.  
POSTMENOPAUSAL STATUS 
 Coronary heart disease is relatively uncommon in premenopausal 
women but men exhibit a higher incidence of coronary artery disease at early 
age, as well as higher mortality rates from it, the gap narrows substantially after 
both natural menopause and bilateral oophorectomy. Women seen with a first 
myocardial infarction tend to be older and have higher mortality than men with 
first myocardial infarction. 
 A wide range of factors may explain the increased risk of coronary 
artery disease after menopause, including adverse changes in lipid and glucose 
metabolism that result in an increase in LDL cholesterol and a decrease in HDL 
cholesterol, an increase in glucose intolerance and changes in haemostatic 
factors and vascular function.  Endogenous estrogens appear to play a major 
role in reducing the risk of coronary artery disease in women.  There is also a 
protective effect of vascular function as well as an apparent estrogen related 
protection of LDL from oxidation.  Estrogen also plays one or more roles in 
maintaining normal haemostasis and improving glucose tolerance but recent 
studies showing Hormone replacement Therapy fails to demonstrate the benefit 
indeed showing increased incidence of Cardiovascular events, ca brest, 
Thromboembolism.43 
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FAMILY HISTORY & GENETIC FACTOR  
 More than 35 case control and prospective studies have consistent 
identified an association between CHD and a History of 1st degree relatives 
with early onset CHD.  
 Ischemic heart disease is well recognized as clustering in families.  At 
present 40% of risk of developing ischemic heart disease is contributed by 
genetic factors and 60% by environmental factors.  
 Recent studies have identified a common deletion polymorphism of 
ACE gene which is associated with increased level of ACE and risk of 
coronary artery disease.  Genetic markers such as LDL receptor, factor V 
leiden are also other genetic markers.  Genetic factors may play a role by 
ascertaining direct effects on the arterial cell structure and metabolism as they 
may act indirectly via such factors as hypertension, increase LDL, diabetes 
mellitus, obesity, Lipoprotein-a, etc.  
 Coronary artery disease affects Indians 5-10 years earlier than other 
communities. There is a parallel corollary between coronary artery disease in 
Indians and the malignant course of rheumatic fever, rheumatic heart disease 
with associated severe pulmonary hypertension observed by Indian 
cardiologists. Siblings and children of early CHD patients should be screened 
for CHD risk factors.   
DIET 
 Diet is an important component of any prevention program in as much 
as weight reduction can improve dyslipidemia, hypertension and diabetes.  One 
of the most consistent finding in dietary research is that individuals who 
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consume higher amounts of fresh fruits and vegetables have lower rates of 
heart disease and stroke.  Two randomized clinical trials of dietary inventions 
showed that the risk of cardiac death or acute myocardial infarction was 65% 
lower.  Low fat diet has been shown to reduce the risk of myocardial infarction 
in healthy individuals and may even cause regression of coronary artery 
disease.  In the opposite direction, saturated and transfatty acids appear to 
increase the coronary artery disease.  Antioxidant, vitamins, folate supplement, 
whole grains, fiber, fish and fish oil seems to have a beneficial effect.  
 The WHO expert committee has given the following dietary changes to 
be appropriate for high incidence populations.  
1. Reduction of fat intake to 20-30 percent of total energy intake. 
2. Consumption of saturated fats must be limited to less than 10% of 
total energy intake: some of the reduction in saturated fat may be 
made up of mono and poly unsaturated fats.  
3. A reduction of dietary cholesterol to below 100 mg per 1000 k 
cal/day 
4. An increase in complex carbohydrate consumption (vegetables, 
fruits, whole grains and legumes). 
5. Reduction of salt intake to 5g daily or less.  
Thus a healthy diet can considerably lower the risk of myocardial 
infarction.  
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FIBRINOGEN  
 Several studies have shown that plasma fibrinogen level predicts the 
future risk of MI and stroke.  This indicate that individual with fibrinogen 
concentration of in the upper third of the control distribution have a relative 
risk of future Cardio Vascular Disease 2.0 to 2.5 times of that individuals with 
lower level.44 
 Plasma fibrinogen critically influences platelet aggregation and blood 
viscosity, interacts with plasminogen binding and in combination with 
thrombin mediates the final step in clot formation.  In addition, fibrinogen 
associates positively with age, obesity, smoking, diabetes, and LDL-C and 
inversely with HDL-C, alcohol use physical activity and exercise level.45 
 Despite major genetic determinants of fibrinogen concentration, 
substantial, variation in plasma levels result from environmental factors.  
Smoking cessation increased exercise and weight loss can reduce fibrinogen 
concentration.  Fibric acid derivatives also reduce fibrinogen, apparently 
through PPAR-a mechanism.  
MARKERS OF INFLAMMATION PREDICT FUTURE RISK  
 These markers include nonspecific acute phase remnants such as hs-
CRP, adhesion molecules such as ICAM-1 that are involved in mononuclear 
cell attachment to the vascular endothelium and cytokines such as IL-6 and 
Tumor necrosis factor.  A large body of consistent evidence validates use of 
acute phase reactants such as CRP and serum amyloid A as markers of risk.  
Serum amyloid A can bind to HDL particles perhaps rendering them less 
protective against vascular inflammation.  
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 Single, non fasting measure of CRP a potent predictor of first 
cardiovascular event among man, women, elderly.  Those with metabolic 
syndrome, Dm, and smokers.46 
 CRP increased in all the CHD risk factors, and decreased with  moderate 
alcohol intake, physical activity, wt loss, and drugs like statins, fibrats, niacin 
ARB.47 
hs – CRP will likely prove the most clinically useful because it is easy 
and inexpensive to measure with commercial assay.  hs-CRP increases the 
relative risks of future event of coronary artery disease 3 to 4 times higher than 
those with lower hs CRP levels.  
INJECTION  
 Chronic infection with agents such as chlamydia pneumonia, 
helicobacter pylori, herpes simplex virus or cytomegalovirus virus can lead   to 
systemic inflammation.  Such observations have heightened interest in the 
hypothesis that infection may contribute to coronary risk.  Several cross 
sectional and retrospective studies have identified chlamydia species as well as 
viral particles in atheromatous lesions.  It is important to recognize several 
mechanisms by which infection might contribute to plague instability. Eg. 
Chlamydia species have been reported to induce macrophage foam cell 
formation and increase procoagulant activity human atneromas often contain 
chlamydia heat shock protein 60, an effector of activation of macrophages, 
endothelium and matrix metalloproteinase expression.  
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MINOR RISK FACTORS  
 Copper deficiency and zinc excess – This leads to secondary 
hypercholesteremia leading to increased risk of myocardial infarction. 
 Water hardness – Water hardness is inversely related to ischemic heart 
disease.  Soft water is generally associated with greater risk of heart disease.  
Metals like magnesium chromium selenium and zinc have protective effect 
against myocardial infarction.  Cadmium, Manganese and Lead have harmful 
effects and increase risk for myocardial infarction.  
Heavy coffee drinking – Produce tachycardia, arrhythmia and extra 
systole and thus predispose individuals to increased risk of myocardial 
infarction.  Lipid rich fractions from boiled coffee increases serum cholesterol 
level thus increasing the risk for myocardial infarction.  
 Blood Group – Persons with type O blood group appear to be at a lesser 
risk for myocardial infarction.  Research is still on going to find out the 
correlation of such an association.  
CLINICAL SPECTRUM OF MYOCARDIAL INFARCTION 
SYMPTOMS  
 In up to one half of cases, a precipitating factors appears to be present 
before AMI, such as vigorous physical exercise, emotional stress, or medical or 
surgical emergency illness.  Although MI can present at any time of the day, 
circadian variation  have been reported such as clusters are seen in the morning 
with in few hours of awakening.  
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- Pain in most common presentation.  
- Pain is deep and visceral: adjuncts commonly used are heavy, 
squeezing, crushing occasionally stabbing or burning.  
- Accompanying symptoms are weakness, sweating, nausea, 
vomiting, anxiety, sense of in pending doom.   
Atypical presentation 
- Acute confusion (elderly)  
- Profound weakness 
EXAMINATION 
 Signs of sympathetic activation – Pallor, sweating, tachycardia 
 Signs of Vegal activation – Vomiting bradycardia 
Signs of Impaired Myocardial function– hypotension, oliguria, cold 
peripheries, narrow pulse pressure, raised JVP, third heart sound, quiet 
first heart sould, diffuse apical impulse and lung crepitations.  
Signs of tissue damage – fever, 
Signs of complications – eg. Mitral regurgitation, pericarditis  
Laboratory Findings  
 The laboratory tests of value in confirming the diagnosis of myocardial 
infarction are divided into four groups.  
1. The electrocardiogram. 
2. serum enzyme changes 
3. Cardiac imaging. 
4. non specific indexes of tissue necrosis and inflamation  
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Non Specific Reactions  
 Polymorphonuclear Leukocytosis appears within hours, lasts for 3 to 7 
days;  
 ESR increases – Peaks at first week and remain elevated for 1 to 2 
weeks.  
ELECTRO CARDIOGRAPHY 
Earliest ECG changes are usually ST elevation.  Later on there is 
diminution in the size of R wave and in Transmural (full thickness) infarction – 
Q wave develops.  Subsequently T wave becomes inverted because of change 
in ventricular repolarisation.  
 In subendocardial infarction there is ST/T wave changes without Q 
waves or prominent ST elevation often accompanied by some loss of R waves 
in the leads facing the infarct.  
Anteroseptal infarction   V1 – V4 
Anterolateral infarction   Lead I, aVL, V4 – V5 
Extensive anterior wall infarction   Lead I, aVL, V1 – V6 
Inferior infarction    II, III and aVF 
Posterior wall infarction   Reciprocal changes of ST depression  
and tall R wave in leads V1 – V2  
Right Ventricular Infarction  V4R – ST Segment Elevations.  
Bio Markers  
 Certain proteins, called serum cardiac biomarkers, are related from 
necrotic heart muscle after STEMI. The rate of liberation of specific protein 
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differs depending on their intracellular location, molecular wt, local blood and 
lymphatic flow.  
 
 
Tpoponin 1 and II 
 More specific, are released in 4 to 6 hrs peak at 1 – 2 days remain 
elevated upto 7 days, So not useful in reinfant.  
CPK MB :  
Reduced with in 4 to 8 hrs return to Normal in 48 – 72 hrs so useful in 
reinfarction, drawback in non-specific.  
 AST starts to rise about 12 hours after infarction and reaches a peak on 
first or second day, returning to normal within 3 to 4 days. 
 LDH starts to rise after 12 hours reaches a peak after 2 or 3 days and 
may remain elevated for a week more.  
CHEST X-RAY 
 This demonstrates signs to left ventricular failure, cardiomegaly and 
coexisting cardiac or pericardial diseases. 
Days after onset of MI 
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ECHO 
 Early deduction of wall motion abnormalities can aid in management 
decision and estimation of the Left Ventricular function is useful 
prognostically, useful to detect in complications such as cardiac rupture, 
Ventricular septal defect, pericardial effusion.  
RADIONEUCLOTIDE SCANNING – OTHER IMAGING MODALITIES  
 Isotope used are 201Ti or 99mTc – sestambi. In the presence of fixed 
coronary stenosis there is an inability to increase myocardial perfusion in the 
territory supplied by the stenotic artery creating a flow difference and 
inhomogeneous distribution of isotope.  Extremly sensitive in distinguishing 
acute infarct from chronic scar.  
CARDIC CATHETERIZATION AND ANGIOGRAPHY 
 These remain the only technique that can define coronary anatomy with 
sufficient precision to support decisions regarding coronary surgery or catheter 
based interventions in patients with coronary artery disease. 
MANAGEMENT  
Early management 
o Bed rest 
o High flow oxygen if Spo2 < 90% 
o Oral Aspirin, Clopidogrel, Nitroglycerine, atorvastatin 
o IV access 
o IV analgesic with opiates 
o IV antiemetic 
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o Thrombolysis with IV streptokinase 
o IV   adrenoreceptor antagonist 
o ACE Inhibitors  
o Continuous cardiac monitoring and ECG 
o Detect and treat complications early 
Coronary thrombolysis helps restore coronary patency, preserves left 
ventricular function and improves survival.  Successful thrombolysis leads to 
reperfusion with relief of pain, resolution of acute ECG changes and sometimes 
transient arrhythmias.  The sooner the patient is treated the better the results. 
 Clinical trials have shown that appropriate use of these drugs can reduce 
the hospital mortality of myocardial infarction by between 25% and 50% short 
term mortality was reduced from 13% to 8% 
 Streptokinase 1.5 Million units in 100 ml saline IV over 1 hour is used.  
It is antigenic and occasionally causes serious allergic manifestation. The drug 
may cause hypotension and is antigenic.  Alteplase is not antigenic and seldom 
causes hypotension.  
ABSOLUTE CONTRAINDICATIONS FOR THROMBOLYSIS  
o Uncontrolled hypertension (>180/110) 
o Active internal bleeding 
o Previous arachnoid or intracerebral hemorrhage  
o Ischemic stroke in past 1 ‘yr’ (s)  
o Aortic dissection.  
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RELATIVE CONTRAINDICATIONS FOR THROMBOLYSIS  
o Anticoagulant with INR > 2  
o Recent surgery (with in 1 month) 
o Known bleeding diathesis 
o Active peptic ulcer disease 
o Pregnancy 
o Hemorrhagic diabetic retinopathy 
o 5 days to 2 years of recent streptokinase  
ANGIOPLASTY 
 Immediate or primary angioplasty of the infarct – related coronary artery 
is relatively safe and effective alternative to thrombolytic therapy 
ANTICOAGULANTS 
 Unfractioned  heparin bolous of 60U/kg followed by initial infusion of 
12U/kg/ hr in addition to reinfarction after successful thrombolysis, reduce the 
risk of thromboembolic complications.  Clinical trials have shown that this 
form of therapy produces a small reduction in short term mortality but also 
increases the risk of cerebral hemorrhage and of other bleeding complications.  
BLOCKERS, NITRATES AND OTHER AGENTS 
 Acute  adrenoreceptor antagonist use with IV metaprolol relieves pain, 
reduces arrthymias and improves short term mortality in patients who present 
within 12 hours of onset of symptoms, but should be avoided if there is heart 
failure, heart block or severe bradycardia.  
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 Sublingual glyceryl trinitrate is a valuable first aid measure in threatened 
infarction and IV nitrates are useful for left ventricular failure and the relief of 
recurrent or persistent ischemic pain.  
AGE INHIBITORS 
 ACE Inhibitors should be prescribed in all hoemodynamically stable 
patients it reduces the ventricular remodeling with subsequent reduction in the 
risk of left heart failure.  It should be prescribed within 24 hours. 
COMPLICATIONS OF MYOCARDIAL INFARCTION 
o Ventricular Dysfunction 
o Cardiogenic Shock 
o Right Ventricular Myocardial Infarction 
o Mechanical Causes of Heart Failure 
             Free wall rupture 
             VSD 
             MR 
o Arrythmias 
1. Ventricular premature beat 
2. Ventricular tachycardial/fibrillation 
3. Accelerated Idio ventricular rhythm 
4. Supraventricullar arrythmias  
5. Sinus bradycardia 
6. Atrioventricular conduction disturbances 
7. Asystole 
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o Other complications 
1. Recurrent chest discomfort 
2. Pericarditis, pericardial effusion 
3. Thromboembolism 
4. Left Vetricular anerurysym 
5. Dressler’s Syndrome 
POST INFARCTION RISK STRATIFICATION AND MANAGEMENT 
 In stable patients sub maximal exercise stress testing should be carried 
out prior to hospital discharge to detect residual ischemia and ventricular 
ectopy, and to provide the patient with a guideline for exercise in early 
recovery period.  Alternatively, or in addition a maximal exercise stress test 
may be carried out 4 to 6 weeks following infarction. Evaluation of left 
ventricular function at rest and during exercise is usually warranted as well 
recognition of a depressed left ventricular ejection fraction by ECHO or 
radioneucleotide ventriculography helps the physician with the selection of 
pharmacologic measures to improve long term outcome.  Patients with angina 
induced at relatively low work loads, those who have a large reversible defect 
on perfusion imaging or a depressed ejection fraction and demonstrate 
ischemia, and those in whom exercise provokes symptomatic ventricular 
arrhythmias should be considered at high risk for recurrent myocardial 
infarction or death from arrythmia and cardiac catherisation with coronary 
angiography or invasive eletrophysiologic evaluation.  
 A variety of secondary preventive measures are at least partially 
responsible for improved long term mortality and morbidity following 
 37 
myocardial infarction.  The benfits and use of beta blockers, antiplatelet agents 
and anticoagulants and ACE inhibitors are discussed above.  Finally risk 
factors for atherosclerosis should be discussed with patient.  In particular 
efforts should be made to ensure the cessation of smoking and the control of 
hypertension and hyperlipidemia.  Additionally regular physical exercise and 
reduction of emotional stress should be encouraged.  
RISK FACTOR ANALYSIS 
 Studies by Kaul et al.48 showed data about the risk factors for MI. 
Smoking is the most common risk factor. 
 Smoking  - 76.2% 
 Hyperlypidemia - 36% 
 Hypertension  - 32% 
 Family history - 28% 
 Diabetis Mellitus - 5% 
 Multiple risk factor - 56% 
 Fourmers propsective study49 on young MI showed smoking (78%) the 
most common risk factor. 
 Study conducted in Singapore50 by PA Tambyah et al. showed smoking 
(84%) the most common risk factor. 
Ht 19% 
FH 20% 
Smoking 84% 
DM 16% 
Hyper cholesterolemia 56% 
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 Dolder M. et al.51 done a study in 9 countries showed smoking (80%) 
the most common risk factor. 
 Studies from South African52 journal showed smoking (79%) and 
hypercholesterolemia (52%) the common risk factor. 
 Nitter hauge et al B53 did a study on 66 patients about risk factors the 
studies revealed, that smoking was present in 86% 
Smoking 86% 
Hypercholesterolemia 35% 
Systolic hypertension 24% 
Diabetes Mellitus Nil 
 
 PK Biswas A. Dasbiswas et al (1994) B54 study on Risk factor and 
angiographic profile of coronary artery disease in young showed that smokers 
and hyperlipidemics were the most affected.  
PK BISWAS A. DASBISWAS STUDY 
Smokers > 10 Cigarettes/day 56.4% 
Total cholesterol > 240 mg% 30.6% 
HT BP > 160/85 mm Hg 11.3% 
Family history of coronary artery disease 11.3% 
Obesity (> 20% of ideal body weight) 9.7% 
Diabetes Mellitus 6.5% 
Hyperuricemia (> 7 mg%) 3.2% 
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 In studies done by Dwivedi, Girish, Chaturvedi, Sanju,et.al55 which 
comprised of 70 young coronary artery disease patients < 40 Years.  There 
were 56 (80) males and 14 (20%) females, mostly (67.14%) belonging to 36 – 
40 age group.  More than half the patients (53%) were from low socio 
economic group. 
 61.42% were chronic smokers and all of them were males.  18.8% 
subjects gave history of premature coronary artery disease.  Hypertension was 
detected in 51.42%.  Obesity observed in 35.71%.  Underweight was noted in 
14% of subjects.  80.35% males and 91.66% females manifested upper segment 
obesity.  Hypercholestrolemia was seen in 41.66%.  7.14% were diabetic.  
Family history of premature coronary artery heart disease in 42.8% and 
previous hypertension in 42.8% and central obesity (.9.166%) were three 
distinct risk factors in young female subset of patients.  
DIWVEDI, GIRISH STUDY 
Males 80% 
Females  20% 
Chronic smoker 61.42% 
Premature coronary artery disease 18.8% 
Hypertension 51.42% 
Obesity  35.71% 
Diabetes 7.14% 
Family history 42.8% 
Hpercholesterol 41.66% 
Low Socio Economic Status 53% 
 40 
 Studies by Marty AK et al56 showed the following data about the risk 
factors for acute myocardial infarction.  Smoking was the most common risk 
factor present.  
 
Smoking 66% 
Hyperlipidemia 44% 
Stress 40$ 
Hypertension 28% 
Family history 28% 
Diabetes Mellitus 18% 
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AIM OF THE STUDY 
 
1. To study the clinical spectrum of myocardial infarction. 
2. To study and assess the classic atherogenic risk factors taking into 
consideration both modifiable and non-modifiable factors.  
3. To study the multiplicative effects of different combinations of the 
different Risk factors.  
4. To thing more in terms of preventive cardiology than palliative 
cardiology.  
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MATERIALS AND METHODS 
 This case control study was conducted at the intensive cardiac care unit 
and medical wards of Chengalpattu Medical College Hospital, Chengalpattu 
during the period of September 2010 to November 2010. 
 The study was done as a case control study retrospectively. 
 The patients admitted with the clinical features of myocardial infarction 
with ECG changes suggestive of MI, elevated CKMB and SGOT, 
positive ECHO findings were taken as cases. 
 The patient admitted with chest pain and the ECG, CKMB and 
SGOT,ECHO were not suggestive of myocardial infarction were taken 
as controls.  
 Two hundred patients were examined and a detailed history with regard 
to risk factor analysis was made. 
 The age group of less than 40 years were taken for study 
 Both female and male patients were taken for study 
 The patients were grouped into three categories according to the age 20 
to 28, 29 to 34 and 35 to 40.  
 The cases and controls were matched according to the age and sex.  
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OBSERVATIONS 
 In the study of clinical spectrum of myocardial infarction chest pain and 
its association with sweating, nausea, vomiting, breathlessness and palpitation 
were all taken into account and the percentage of each was studied. 
 Physical signs like hypertension, hypotension, raised JVP, edema, S3, S4 
and wheeze were all looked for. 
 Smoking was considered as mild (upto 10 cig/day), moderate (10-15 
cigarettes/day) heavy (> 15 cigarettes/day) 
 Hypertension was considered by documented history of hypertension on 
medication or BP > 140/90 mm Hg. 
 Diabetes Mellitus was considered either by documented history of 
treatment or with a fasting blood sugar level  126 mg and post prandial  200 
mg. 
 Serum choleterol was done for all patients. A lipid profile was also 
performed. 
 Triglyceride value > 160 mg/dl and HDL < 40 mg/dl was taken into 
study. 
 LDL level should ideally be less than 130 mg/dl the LDL level was 
graded as <130, 130-160 & >160 mg/dl. 
 Questionnaire for personality traits was asked and patient’s categorised 
as type A & type B. 
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 Patients were grouped into three categories according to their age as 20-
28, 29-34, 35-40. 
 A detailed family history, socioeconomic status, occupation, diet and 
lifestyle were obtained. 
 BMI was calculated by using wt/ht2 and weight/hip ratio was calculated. 
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RESULT AND OBSERVATION 
CLINICAL PRESENTATION – SYMPTOMS  
 92% of the patients with myocardial infarction had mild to severe chest 
pain.  62% presented with H/o excessive sweating, 30% presented with fatique 
and 22% associated with breathlessness.  
 The character of pain was assessed to be sharp stabbing with radiation in 
42%.  The radiation was mainly to the left arm, jaw, epigastric region. 2 patient 
presented with acute onset of giddiness, one patient with arm pain alone.  
CLINICAL PRESENTATION 
Symptoms No. of Cases (Total 100)  
Chest pain (angina mild to severe) 92 
Chest pain with sweating  62 
Radiation + 42 
Fatigue  30 
Breathlessness 14 
Nausea and vomiting  9 
Breathlessness without chest pain  8 
Palpitation  6 
Epigastric pain  5 
 
CLINICAL PRESENTATION – SIGNS  
 Hypertension was the most common presenting sign. 56% of Patient 
were normal, Mitral regurgitation in 3%, S3 found in 8%, Crackles in 16%.  
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Signs No. of Cases  
Normal Cardiovascular Findings  56 
Hypertension  42 
Crackles  16 
S3 9 
S4 5 
Hypotension 7 
Wheeze 5 
Associated MR 3 
Apical shift 2 
Raised JVP 2 
Edema  1 
 
NUMBER OF CASES ACCORDING TO KILIP’S CLASSFICATION 
 Killip gave a classification depend on the status of cardiac pump 
function, estimated clinically. 
 Class I - No sign of pulmonary or venous congestion. 
 Class II - Moderate heart failure as evident by rales at lung 
bases, S3 gallop, tachypnea or right sided heart 
failure signs.  
 Class III - Severe heart failure, pulmonary edema 
 Class IV - Shock with systolic pressure < 90mm Hg,  
Evidence of peripheral vasoconstriction, Peripheral 
cyanosis, mental confusion, oliguria.  
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NUMBER OF CASES ACCORDING TO KILLIP’S CLASSIFICATION  
Class  No. of Cases  
I 84 
II 11 
III 4 
IV 1  
 
Age Distribution 
Age No of person 
20 – 28 15 
29 – 34 32 
34 – 40 53 
Total 100 
 
The youngest age is 22years who is a lorry driver,and heavy smoker for 
5 years.  
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Sex Distribution 
Sex No of person 
Male 89 
Female 11 
Total 100 
 
89
11
0
20
40
60
80
100
Male
Female
 
Age sex ratio 
Age Male Female 
20 – 28 15 (16.9%) 0 
29 – 34 30 (33.7%) 2 (18.2%) 
35 – 40 44 (49.4%) 9 (81.8%) 
Total 89 11 
 
Females were somewhat elder to their male counter parts.most of them 
belong to 35-40 group. 
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Family history 
 With MI With out MI 
Positive 68 34 
No 32 66 
 
OR = 4.13 (95%CI = 2.20 to 7.79) 
Chi sq test = 23.13              p value = 0.0000 significant 
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 Family history was found in 68% cases. We have included coronary 
artery disease in all age groups. It is important to remember that positive family 
history of coronary artery disease in the young has genetic, environmental and 
life style components which ultimately culminate into young coronary episodes 
into the family. 
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Smoking vs MI 
 
 With MI With out MI 
Smoker 82 38 
Nonsmoker 18 62 
 
 
OR = 7.43 (95%CI = 3.7 to 15.07) 
Chi sq test = 40.33              p value = 0.0000 significant 
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 Smoking increases the risk of MI upto 8 folds. 
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HDL vs MI 
 
 With MI With out MI 
<40 72 32 
>40 28 68 
 
OR = 5.46 (95%CI = 2.86 to 10.51) 
Chi sq test = 32.05              p value = 0.0000 significant 
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LDL vs MI 
 
 With MI With out MI 
>130 81 32 
<130 19 68 
 
OR = 9.06 (95%CI = 4.5 to 18.42) 
 
Chi sq test = 48.85              p value = 0.0000 significant 
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HT vs MI 
 
 With MI With out MI 
With HT 69 39 
Without HT 31 61 
 
OR = 3.48 (95%CI = 1.87 to 6.53) 
Chi sq test = 18.12              p value = 0.0001 significant 
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Obesity vs MI 
 With MI With out MI 
Obese 37 12 
<28.6 63 88 
 
OR = 4.31 (95%CI = 1.98 to 9.53) 
Chi sq test = 16.89              p value = 0.0001 significant 
 
 With MI With out MI 
<23 24 56 
23.1 – 28.6 39 32 
>28.6 37 12 
 
Chi sq test = 26.25              p value = 0.0000 significant 
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SEDANTARY LIFE STYLE  
Total No. of Patients  
with MI H/O sedentary life style 
Active Physical 
activity 
100 38 62 
 
Sedentary life style was noted in 38% of patients with myocardial infarction. 
 
Waist hip ratio – male vs female 
 Male Female 
<desired level 29 2 
>desired level 60 9 
 
Desired level for male < 0.9 
Desired level for female < 0.8 
OR = 2.17 (95%CI = 0.4 to 15.63) 
 
DM vs MI 
 With MI With out MI 
DM+ 17 8 
DM- 93 92 
 
OR = 2.1 (95%CI = 0.81 to 5.62) 
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Economic Status of Patients under Study 
39
102
6
43
 
  49% of patients belonged to low socio economic group, while 43% 
came from middle income group and only 8% were from upper group.  
Existence of coronary artery disease in the lower socioeconomic group of 
people in the polis of India is a fact, which is being observed in this country.  
The scenario has changed considerably since the 70’s, when low socio 
economic group of people in rural and semi urban India used to do a lot of 
physical labour and hard work and incidence of ischemic heart disease was 
reported to be low in such cases.  These days many of the young able bodied 
people migrate to neighboring metropolis and adopt faulty life styles which 
make them prone to coronary artery disease.  
 80% of young coronary artery disease subjects were chronic beedi 
smokers.  All of them were males and they come from low socioeconomic and 
middle income segment of the society.  Another interesting observation was the 
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fact that only 35% males had smoking as the only conventional risk factors, 
however many of them had three of four major risk factors.  
SOCIO ECONOMIC STATUS OF PATIENTS 
SES No. of patients with MI 
Poor 10 
Lower middle  39 
Middle  43 
Upper middle  6 
Rich  2  
 
It is also well known that combination of major risk factors like 
smoking, hypertension and dyslipidaemia in an individual exerts a 
multiplicative effect on coronary artery disease.  The risk increases as much as 
9-16 times when all three risk factors are present.  
Psychosocial stress : 
 Psychosocial stress was found to be present in 38% of the patients with 
myocardial infarction.  They were all Type A personalities with an 
evidence of stressful environment. 
Diet : 
 Dietary history showed that myocardial infarction was more common in 
non-vegetarians than vegetarians.  
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AREAS OF INFARCTION  
 In our study the most common site of infarction was found to be anterior 
wall accounting for 47% of cases.  
 
INFARCT SITE CASES 
Extensive ant wall infarct  47 
Anteroseptal  24 
Inferolateral  8 
Inferior + Right Ventricle  5 
Anterior + Inferior  4 
Inferior + Posterior  8 
Anterolateral  4  
 
TYPE OF INFARCTION  
 64% of patients admitted with myocardial infarction had a Q Wave in 
ECG.  
Q Wave  64% 
Non Q Wave  36% 
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SUMMARISING THE RESULTS 
Males  89% 
Smoking  82% 
Hypercholesterolemia  79% 
Family History  68% 
Low socioeconomic status  49% 
Hypertension  39% 
Sedentary lifestyle  38% 
Psychosocial stress  38% 
Obesity 37% 
Diabetes Mellitus  15%  
 
COMBINATION OF RISK FACTORS IN MI 
HT + Obesity + DM + Hypercholesterolemia  5 
Hypercholesterolemia + Obesity + DM 10 
Obesity + Hypertension  15 
Obesity + Diabetes mellitus  7 
Obesity + Hyper cholesterolemia  21  
 
Some had clustering of several coronary risk factors.  
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DISCUSSION 
 This Hospital based study of clinical spectrum and risk factors in the 
young myocardial infarction patients the commonest symptoms was chest pain 
and the commonest sign was hypertension.  Risk factor analysis showed that 
smoking, hypercholestrolemia, positive family history, hypertension, obesity 
were frequently associated with young myocardial infarction patients.  We are 
comparing the results of the study with the previous studies.  
PRESENTING SYMPTOMS AND SIGNS 
 In our study most common presenting symptom was chest pain.  Other 
anginal equivalence accounted for 8% of presentation.  In our study 15% of the 
patient were diabetics.  Almost all the diabetic patient presented with anginal 
equivalents.  Similar observations have been made in other studies also i.e. 
Mrgolin JN, Kinnel WB62, Fienleich M, et al. (23%) Clinical features of 
recognized MI silent and symptomatic in AMJ. Cardial 1973 : 32:1, PA 
Tambyah et al.50 
 The most common cardiovascular sign was hypertension (42%) similar 
observations have been made in other studies also i.e. Marty56 AK Das AK et 
al. (41%), Nitter Haugh53 et al (24%), Dwivedi55 et al (51.42%) studies.  
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RISK FACTORS 
Risk factors in young coronary artery disease: Indian Scenario 
 Tambya 
1999 
n=32 
Dolder 
1985 
n=240 
Rhotak 
1978 
n=85 
Kaul 
MD 
1986 
n=105 
Gupta 
R 
1994 
PK 
Biswas 
1994 
Dwiv 
2000 
n=70 
Kellelly 
1982 
N=145 
As per 
the 
present 
study 
Male : 
Female 
NR NR NR 9:1 NR NR 4:1 9:1 9:1 
Family 
history % 
20 12 55 28 NR 13.3 42.8 31 68 
Smoking 
% 
84 80 17 76 42 56.4 61.42 80 82 
Hyper-
tension % 
19 15 15 32 13 11.3 51.42 11 39 
Obesity % 15 NR 15 NR 10 9.7 35.71 27 37 
Diabetes 
Mellitus % 
16 10 NR 5 4 6.5 7.14 NR 15 
High 
cholesterol 
% 
56 46 30 36 53 30.6 41.66 70 81 
NR – not recorded 
SMOKING : 
 In our study 82% of the patients were smokers all of them are males.  
The probable reason being the atherosclerotic process accelerated by enhanced 
oxidation of LDL-C and reduced the levels of HDL-C. Smoking also impairs 
endothelium, increases inflammatory markers and fibrinogen, causes platelet 
aggregation and increases monocyte adhesion to endothelial cells.  In earlier 
studies too similar observations have been made i.e. Kaul MD et al48 m 1986 
(76%), PA. Tambyah et al. 50 (1999) 84% Dolder M et al51 (80%) 
Swedarsen et al52 1987 (79%) Dwivedi55 et al. (61.42%) 
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Hypercholestrolemia: 
 In our study 81% of patients were found to have dyslipidemia.  
Hypercholestrolemia accelerates the atherosclerotic process.  In addition 
hypercholestrolemic patients who are associated with obesity, insulin resistance 
also produces a prothrombotic state due to increased level of PAI – I and 
Fibrinogen Similar observations have been made in other studies also i.e. 
Dolder et al (54%)51 (68%) 1987, PK Biswas A Dasbiswas S Roy54 et al 
(30.6%) in 1994, VNS61 study (92.8%) in 1971 BOM61 study (70%) in 
1970, Knennelly Bm etal study58 (70%) 
Family History : 
 In our study 68% of the patients were found to have positive family 
history.  The genetic factors contribute to the risk of developing ischemic heart 
disease.  The risk is as high as 40%.  Common deletion polymorphism of 
angiotension conveting enzyme (ACE) gene associated with increased level of 
ACE adds to the risk of coronary artery heart disease.  Genetic factors such as 
LDL receptor factor V Leiden are also other genetic markers. In earlier studies 
too similar observation have been made i.e. Marty56 AK Das AK et al (28%), 
PK Biswas A Dasbiswas S Roy54 et al (11.3%) in 1994, Dwivedi55 et al 
(42.8%) in 2000, VNS60 study (25%) in 1971, Rhotak61 study (55%) in 
1978, Kennelly BM et al58 (31.%) 
Age Sex Ratio: 
 In our study males were 89% and females were 11% (Male & Female 
ratio is 6.69:1) Significantly major risk factors like smoking, psychosocial 
stress and hypertension were among men as compared to women.  In females 
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the risk of developing coronary artery disease started 10 years later than male.  
This is presumably due to hormonal factors.  The most common age groups 
affected were between 36 to 40 years.  This denotes increasing incidence of 
myocardial infarction with increase in age.  Similar observations have been 
made in other studies also i.e. Dwivedi55 et al (4:1) in 2000, Bikanes61 study 
(8:1) in 1994, VNS61 study (8:3:1) in 1971, old Delhi61 study (9:1) in 1986.  
Hypertension: 
 In study 39% of the patients were found to have hypertension.  The 
probable reason being the accelerated atherosclerosis, increased left ventricle 
wall stress, left ventricle tension and stroke work.  Other reasons like left 
ventricular hypertrophy, abnormal coronary flow reserve and abnormal 
vasomotor response and micro vascular dysfunction.  Similar observation have 
been found in other studies also i.e. Marty56 AK Das AK et al (28%), Nitter 
Haugh53 et al (24%) Dwivedi61 et al (51.42%) in 2000. Kaun MD et al 
32%68.  
Psychosocial stress : 
 In our study 38% of patients were found to have psychosocial stress.  
The probable reason is depression, job stress, social isolation, Type A 
personality are some of the factors contribute to an elevated risk of Coronary 
artery heart disease, although further data are needed to confirm this 
relationship.  Similar observations have been made in other study also. I.e. 
Marty56 AK Das AK et al (40%) 
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Obesity : 
 In our study 37% of patients were found to have obesity.  Obesity is an 
important risk factor in the development of coronary heart disease.  Obesity is 
associated with increase in total and central blood volumes, cardiac output and 
left ventricular filling pressure. When the additional effects of hypertension and 
glucose tolerance are added, the adverse impact of obesity is even more 
evident.  Obesity especially central obesity is associated with an atherogenic 
lipid profile.  Similar observation have been made in other studies also i.e. 
Dwivedi55 et al (35.71%) in 2000, PK Biswas A (9.7%), VNS61 study 
(35.7%) in 1971, old Delhi61 study (11%) in 1986, Rhotak61 study (15%) in 
1978, BOM61 study (23.5%) in 1979, Kennely Bm etal58 (77%) 
Diabetes Mellitus : 
 In our study 15% of patients were found to have diabetes.  The reason 
being it impairs endothelial and smooth muscle function and appears to 
increase leukocyte adhesion to vascular endothelium, a critical early step in 
atherogenesis.  And also insulin resistance also produces a prothrombotic state 
due to increased level of PAI – I and fibrinogen.  Similar observations have 
been made in other studies also i.e. Marty56 AK Das AK et al (18%), PK 
Biswas A (6.5%), VNS61 study (17.8%) in 1971, old Delhi61 study (3%) in 
1986, Dwivedi55 et al (7.14%) in 2000, Chennai61 study (18%) in 1991. 
Dolder m et al. 10%51 
 
 65 
CONCLUSION 
The following are conclusions that could be inferred from the study on 
the clinical spectrum and risk factors among young myocardial infarction.  
 The most common symptom was chest pain.  
 The most common cardiovascular sign was hypertension.  
 Most of the patients belonged to Killip’s classification I. 
 Most common age group affected was between 36 to 40 years showing 
that risk of myocardial infarction increase proportionately with 
increasing age.  
 Males were commonly affected especially in the younger age group. 
Significantly major risk factors like smoking, psychosocial stress, and 
hypertension were also evident among men as compared to women.  
These factors along with hormonal factors contribute the higher 
proportion of myocardial infarction in young males. 
 Females showed an increased risk of myocardial infarction towards the 
later stages of life presumably due to hormonal factors.  
 Risk factors analyses proved that smoking was the single most important 
risk factor for myocardial infarction. 
 Majority of patients with myocardial infarction had dyslipidemia.  
 Family history of myocardial infarction is an important risk factor 
contributing to myocardial infarction in young individuals.  This is 
probably due to an inter play of both genetic and environmental factors.  
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 Hypertension was closely related with risk of myocardial infarction. 
 The obesity was an important risk factor in young myocardial infarction 
patients probably due to the increasing incidence of sedentary life style.  
 The incidence of diabetic mellitus in young myocardial infarction 
patients was comparatively less than the incidence of other risk factors.  
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SUMMARY 
 Chest Pain is the cardinal symptom in young myocardial infarction.  
Breathlessness, sweating, radiation, vomiting, palpitation, sweating are 
common features symptoms.  Signs of hypertension, S3, S4, crackles, were 
commonly seen.  On few occasions infarction also occurred in the absence of 
physical signs or symptoms.  
 Key factors influencing the development of myocardial infarction were 
non modifiable risk factors such as age, sex, family history.  Smoking is 
probably the single most important risk factor.  There is a strong relationship 
between cigarette smoking and coronary artery heart disease  in young 
individuals.  The risk is also closely related to plasma LDL cholesterol, and 
inversely related to HDL cholesterol concentration.  Obesity particularly 
central or truncal is an independent risk factor.  Additional risk factors such as 
diabetes, physical inactivity added to the adverse impact.  
 The effect of risk factors is multiplicative rather than Additive.  Thus 
people with the combination of risk factors (smoking, hypertension, diabetes) 
have the greatest risk of developing myocardial infarction. 
 Prevention can aim at modifying the risk factors like cessation of 
smoking, reduction of weight, reduction of salt intake, dietary changes, 
increase physical activity and control of psychosocial stress.  This will have a 
tremendous impact in reducing the incidence of myocardial infarction in the 
young.  
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 viii 
CLINICAL PROFORMA 
Name : Height : 
Age : Weight : 
 BMI (Wt/Ht in m2) 
Sex :  
Occupation : Waist/Hip Ratio 
Income/Year Educational Status :  
 
Clinical presentation of illness  
Chest pain – Characters : 
Compressive, Retrosternal, Consistent, Radiating to left arm or root of the 
neck or back of the chest, 
Angina equivalent - 
H/o nausea, vomiting, epigastric pain, jaw pain neck pain, left arm pain. 
Profuse sweating, fatigue, breathlessness, palpitation, syncope  
 
Time of onset of symptoms : 
Admission time :     Therapeutic Window.  
 ix 
 
Risk Factor Identified :  
1. Smoking :                      Beedies/Cigarettes smoking / Others 
                                          No. of Cigarettes/day      No. of years of smoking : 
    Other forms of tobacco : Nasal snuff / tobacco snuff / Chewing  
2. Hypertension :                                              How many years : 
    Under treatment – Yes/No                            Regular / Irregular Rx : 
3. Diabetes Mellitus :                                IDDM/NIDDM (How many years) 
    Treatment : Regular Rs/Newly diagnosed  
4. Family H/o ischemic heart disease  
5. Obesity 
6. Alcohol consumption :                                  Little/Moderate/High 
                                                                         Occasional uses/regular uses 
7. Hyperlipidemia :                                          No. of years            Treatment : 
  
 
III. OCCUPATIONAL HISTORY :  
IV. DIET HISTORY 
 Vegetarian/Non Vegetarian High carbohydrate diet 
 Salt intake    High fat intake 
 Coffee/Tea 
 Living Condition :  Nuclear Family / Joint family /Alone 
     Hut / Tiled House / Independent / Flats 
     Hygiene 
Menstrual history : 
 Menopause :   Years since menopause 
 x 
Sexual history : 
 Frequency of intercourse/extramarital relationship 
Personality :  
Type A Type B 
Never Casual about appointment 
Very competitive Not competitive 
Always rushes  Never  
Impatient when waiting  Can wait  
Tries to do many things at once  Take things one at a time  
Expresses feelings  Does not  
Ambitious  Not Ambitious  
 
General Examination  
 Conscious :     Orientation : 
 PR  BP  RR  JVP 
 Pallor     Cyanosis  
Systemic Examination (CVS) 
 Nature of apical impulse    Abnormal systolic pulsation  
 S1, & S2 intensity    S3 / S4   
Murmur of MR/VSD secondary to septal rupture  
Pericardial friction rub  
(RS) Crackles :     Wheeze : 
 
 xi 
INVESTIGATIONS  
I. Blood  1. Hb 
   2. Sugar 
    Urea 
    Cretinine 
    Electrolytes 
   3. Cardiac enzymes   - Troponin - T 
     Cpk mB 
         SGOT 
   4. Liquid profile  
2. ECG 
3. Chest X-ray 
4. ECHO  
 
 
 
 
 
 
 
 
 xii 
KEY NOTES FOR MASTER CHART 
Sl. No    - Serial Number  
Sx    - Sex 
Clinical spectrum – Symptoms and signs  
CP    - Chest Pain 
RA    - Radiation 
S    - Sweating 
N/V    - Nausea/Vomiting 
DWOC   - Dysponea Without Chest Pain 
DWC    - Dysponea With Chest Pain 
F    - Fatigue 
P    - Palpitation 
EP    - Epigastric Pain  
H    - Hypotension  
RJ    - Raised JVP 
PE    - Pedal Edema 
AS    - Apical Shift  
MR    - Mitral Regurgitation 
R    - Rales 
W    - Wheeze  
 xiii 
Risk Factors 
SM    - Smoking 
HT    - Hypertension 
DM    - Diabetes Mellitus  
FH    - Family History 
OB    - Obesity 
LDL    - Low Density Lipoprotien 
HDL    - High Density Lipoprotein 
LSES    - Low Socio Economic Status 
SL    - Sedentary Life 
PSS    - Psycho Social Stress  
 
MASTER CHART 
 
Sl.No Age Sx 
CLINICAL SPECTRUM  - SYMPTOMS AND SIGNS RISK FACTORS 
CP RA S N/V DW 
OC 
DW 
C 
F P EP H RJ PE AS S3 S4 MR R W SM HT DM FH OB LD 
L 
HD 
L 
LS 
ES 
SL PS 
S 
1 38 M + - - - - + - - - - - - - - - - - + + - - - + + - + + - 
2 28 M + + + - - - + - - - - - - - - - - - + + - - + + + + - - 
3 34 M + + + - - - - - - - - - - - - - - - + - + - - + + - - - 
4 39 M + - + - - - + - - - - - - - - - - - + + + - - + + + - + 
5 40 M + + + - - - - + + - - - - - - - - - + - - + + + - - + - 
6 34 M + + + - - - + - - + + + - - - - + - + - - - + + - + - + 
7 39 M + + + + - + - - - + - - - - - - + - + - + + + + - - + - 
8 33 M + - + - - + - - - - - - - - - - - - + - - + - + + + - + 
9 39 M + + - - - - + - - - - - - + - - + + - + - + + + + + + - 
10 38 F + - + - - - - + - + - + - - - - - - - - - + + + - - + + 
11 28 M + + - - + + - - - + - - - - - - - - + - - + - + - + - - 
12 39 M + + + - - - + - - - - - - - - - - - + + - - + + - + + + 
13 33 M + + - - - - - - + - - - - + - - + - + - - - - + - - - - 
14 34 M + + + - - - - - - - - - - - - - - - + - - + - + - + - + 
15 38 M + - - - - - + - - - - - - - + - + - + + - + + + - - + - 
16 33 M + + - - - - - - - - - - - - - - - - + - - + - + - - - + 
17 39 M + - - - - - + - - - - - - - - - - - + + - + + + - - + - 
18 30 M + - - - - - - - + - - - - - - - - - + + + + - + - - - + 
19 40 M + + + - - - + - - - - - - - - - - - + + - - + - - - + - 
20 39 F + - - - - - - - - - - - - - - - - - - - - + + + - - + + 
21 37 M + - + - - - + - - - - - - - - - - - + + - - + - - - + + 
22 29 M + + + - - - - - - - - - - - - - - - + - - + - + - - - + 
23 34 M + - + - - + + - - - - - - - - - - - + - - - - + - - - + 
24 40 M + - - - - - - - - - - - - - - - - - + + - + + - - - - - 
25 33 M + - - - - - - - - - - - - - - - - - + - - + - - - + - - 
 
MASTER CHART 
 
Sl.No Age Sx 
CLINICAL SPECTRUM  - SYMPTOMS AND SIGNS RISK FACTORS 
CP RA S N/V DW 
OC 
DW 
C 
F P EP H RJ PE AS S3 S4 MR R W SM HT DM FH OB LD 
L 
HD 
L 
LS 
ES 
SL PS 
S 
26 33 M + + + - - - - - - - - - - - - - - - + - - + - + + + - - 
27 29 M + + + - - - + - - - - - - - - - - - + - - + - + + + - - 
28 36 M + - - - - - - - - - - - - - - - - - + - + + - + + + - - 
29 32 M + - + - - - - + - - - - - - - - - - + - - - - - - + - - 
30 39 M + - + + - + + - - - - - - - - - - - - + + + - + + - - - 
31 34 M + - - - - - - - -   - - - - - - - - - + - - - - + + + - - 
32 35 M + - + - - - - - -   + - + - - - - + - + - - + - + - - - - 
33 33 M + - - - - - + - - - - - - - - - - - + - - + - + + + - - 
34 39 M - - - - + - - - - - - - - - - - - - + + + - - - - + - - 
35 39 M + - + - - - - - - - - - - - - - - - + + - + + + + - + + 
36 37 F + - - - - - + - - - - - - - - - - - - - - - + - - - + + 
37 39 F + + + + - - - - - - - - + + - + + + - + + - + + + - + + 
38 27 M + - + - - - + - - - - - - - - - - - + - - + - + + + - - 
39 34 M + + + - - - - - - - - - - - - - - - + + - - - - - - - - 
40 28 M + - + - - + - + - - - - - - - - - - + - - + - - - + - - 
41 31 M + + - - - - + - - - - - - - - - + + + - - + - + + - - - 
42 38 M + - - - - - + - - + - + - - - - - - + - - + + + + + + + 
43 30 M + - + - - - + - - - - - - - - - - - + - - + - + + - - - 
44 37 M + - + - + - - - - - - - - - - - - - + - + + - + - + - - 
45 33 M + - + - - - + - - - - - - - - - - - + - - + - + - - - - 
46 39 M + + + - - - - - - - - - - - - - - - + + - - + + + - + + 
47 32 M + + + - - - + - - - - - - - - - - - + - - + - + + + - - 
48 38 M + + + - - - - - - - - - - - - - - - - + - + - - - - - + 
49 33 F + + + - - - + - - - - - - - - - - - - - - + + + - + + + 
50 38 F + + - - - + + + - - - - - - - - - - - + - + + + - - + + 
 
MASTER CHART 
 
Sl.No Age Sx 
CLINICAL SPECTRUM  - SYMPTOMS AND SIGNS RISK FACTORS 
CP RA S N/V DW 
OC 
DW 
C 
F P EP H RJ PE AS S3 S4 MR R W SM HT DM FH OB LD 
L 
HD 
L 
LS 
ES 
SL PS 
S 
51 34 M + + + + - - - - - - - - - - - - - - + - - + - + - + - - 
52 28 M + - + - - - - - - - - - - - - - - - + - - + - - - + - - 
53 38 M - - - - + - - 
- 
- - - - - - - - - - + + + - + + + - + + 
54 39 M - - - - + - + 
- 
- - - - - - - - - - + + - - + + - + + + 
55 33 M + - + - - - - 
- 
- - - - - - - - - - + - - + - + - + - - 
56 39 F + - + - 
- 
- + 
- 
- - - - + - - - + - - + - + + + + - + + 
57 39 M + + + - 
- 
- + 
- 
- - - - - - - - - - + + - - - - - + - - 
58 34 M + + + - 
- 
- + - - - - - - - - - - - + - - + - + - + - - 
59 38 M + - + - 
- 
- - - - - - - - - - - - - + + + + + + + - + + 
60 39 M + + - - 
- 
+ - + - - - - - + + - + - + + - - + + - + + - 
61 38 F + - - - 
- 
- + - - - - - - - - - - - - + - + + + - + + - 
62 37 M + - - - 
- 
- - - - - - - - - - - - - + - - - - + + - - - 
63 33 M + - + - 
- 
- - - - - - - - - - - - - + - - + - + - - - - 
64 39 M + - + - 
- 
- - - - - - - - - - - - - + + - - - + - + + + 
65 38 F + - + - 
- 
- - - - - - - - + + - + + - + - + - + + + - - 
66 34 M + + - - 
- 
- - - - - - - - - - - - - + + + - - + - - - - 
67 29 M + + + - 
- 
- - - - - - - - - - - - - + - - + - + - + - - 
68 34 M + - + - 
- 
- - - - - - - - - - - - - + - - - - + + - - - 
69 31 F + - - - 
- 
- - - - - - - - - - - - - + - - + - - - + - - 
70 32 M + + + - 
- 
+ - - - + + + + + - + + - + - - - - + + + - - 
71 38 M + + + + 
- 
- - - - - - - - - - - - - + - - + - - - - + - 
72 25 M + - + - 
- 
- + - - - - - - - - - - - + + + + - + + - - - 
73 34 F + + + + 
- 
- + - - - - - - - - - - - - - - + + + - + + - 
74 29 M + + + - 
- 
- - - - - - - - + + - + - + - - + - + + + - - 
75 39 M + - - - 
- 
- - - - - - - - - - - - - + + - + + + - - + - 
MASTER CHART 
 
Sl.No Age Sx 
CLINICAL SPECTRUM  - SYMPTOMS AND SIGNS RISK FACTORS 
CP RA S N/V DW 
OC 
DW 
C 
F P EP H RJ PE AS S3 S4 MR R W SM HT DM FH OB LD 
L 
HD 
L 
LS 
ES 
SL PS 
S 
76 38 M + + + + - + - - - - - - - - - - - - - + - + - + - + + + 
77 34 M - - - - - - - - + - - - - - - - - - + + + + - + - + - - 
78 40 M + + + - - - - - - - - - - + + - + - - + - - + + + - + + 
79 39 M + - + - - - - - - - - - - - - - - - + + - + + + - + + + 
80 39 M - - - - + - - - - - - - - - - - - - + + + - + + + - + + 
81 29 M + - - + - - - - - - - - - - - - - - + - - + - - - - + + 
82 34 M + + + - - - - - - - - - - - - - - - + - - - - + + - - - 
83 31 M + - + - - + - - - - - - - - - - - - + - - + - + - - - - 
84 39 M - - - - - - - - + - - - - - - - - - + - - + + + + + + + 
85 40 M + - - - - - - - - - - - - - - - - - + - - + - + - - + - 
86 38 F - - - - + - - - - - - - + + - + + - - - - + + + + + - + 
87 33 M + - + - - - - - - - - - - - - - - - - - - - - + - - - - 
88 33 M + - + - - - - - - - - - - - - - - - + - - - - + - - - - 
89 39 M + + + - - - - - - - - - - - - - - - + + - - - - - - - - 
90 34 M + + + - - + - - - - - - - - - - - - + - - + - + + + - + 
91 29 M + + + - - - - - - - - - - - - - - - + - - + + - - - + - 
92 30 M + - - - - - - - - - - - - - - - - - + - - + - + - - - + 
93 37 M + - - - - - - - - - - - - - - - - - + - - - - + + + - - 
94 40 M - - - - + - - - - - - - + - - - + - - + - + - + + - - + 
95 28 M + - + - - - - - - - - - - - - - - - + - - + - - - + - - 
96 33 F + + + - - - - - - - - - - - - - - - - - - + + + + + + + 
97 38 M + + + + - + - - - - - - - - - - - - + - - + - + + - - - 
98 31 M + + - - - - - - - - - - - - - - - - + - - + - + + + - + 
99 27 M + + - - - - - - - - - - - - - - - - + - - + - - - - - - 
100 38 M + - - - - - - - - - - - - - - - - - + + - + + + - - + - 
 
